1-2 of 2
Nabil Hagag
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Phase I First-in-Human Study on the Feasibility, Safety, and Antitumor Activity of CD4-Redirected Chimeric Antigen Receptor (CAR) T-Cell Therapy in Patients with CD4+ T-Cell Malignancies (TCM)

Rita Assi, Nabil Hagag, Sherif Farag, Robert V.B. Emmons, Allie Carter, Magdalena Czader, Rafat Abonour, Lionel Apetoh, Yupo Ma, Huda S. Salman
Journal: Blood
Blood (2023) 142 (Supplement 1): 6854.
https://doi.org/10.1182/blood-2023-180111
Published: 2023
Journal Articles

SALL4 is a robust stimulator for the expansion of hematopoietic stem cells

Jerell R. Aguila, Wenbin Liao, Jianchang Yang, Cecilia Avila, Nabil Hagag, Lisa Senzel, Yupo Ma
Journal: Blood
Blood (2011) 118 (3): 576–585.
https://doi.org/10.1182/blood-2011-01-333641
Published: 2011
Includes: Supplemental data